Speaker
Cristiana Priano
(National Center for Oncological Hadrontherapy)
Description
CNAO is one the six centers all around the world able to treat patients affected from cancer by proton and carbon
ions beams. Beams are produced by a synchrotron equipped with two sources. A third source has been recently
installed in order to produce new species that will be interesting both for clinical and R&D purposes.
A new low energy line has been designed, installed and commissioned to transport beams from the new source
to the accelerator. In this paper the new line, called LEBTO3, is presented.
| I have read and accept the Privacy Policy Statement | Yes |
|---|
Author
Cristiana Priano
(National Center for Oncological Hadrontherapy)
Co-authors
Stefano Alpegiani
(National Center for Oncological Hadrontherapy)
Mario Bozza
(National Center for Oncological Hadrontherapy)
Erminia Bressi
(National Center for Oncological Hadrontherapy)
Luciano Falbo
(National Center for Oncological Hadrontherapy)
Sergio Gioia
(National Center for Oncological Hadrontherapy)
Lorenzo Lanzavecchia
(National Center for Oncological Hadrontherapy)
Marco Manzini
(National Center for Oncological Hadrontherapy)
Paolo Meliga
(National Center for Oncological Hadrontherapy)
Riccardo Monferrato
(National Center for Oncological Hadrontherapy)
Anna Parravicini
(National Center for Oncological Hadrontherapy)
Marco Pezzetta
(National Center for Oncological Hadrontherapy)
Marco Pullia
(National Center for Oncological Hadrontherapy)
Simone Savazzi
(National Center for Oncological Hadrontherapy)
Giuseppe Venchi
(National Center for Oncological Hadrontherapy)
Claudio Viviani
(National Center for Oncological Hadrontherapy)
Francesco Zanoli
(National Center for Oncological Hadrontherapy)
